TAG ARCHIVES FOR COVID-19

19
Jan2021

Last year, Heather H. Pierce, JD, MPH and I shared some thoughts about the Belmont Report at 40, and about the evolution and flexibility of the Belmont principles of respect for persons, beneficence, and justice in the face of changing circumstances. As we leave behind the extraordinary year of 2020, I have been thinking about how the pandemic, together with the Black Lives Matter social justice movement, has shone new, and I would say welcome, light on the principle of justice in research. Read more

4
Dec2020

On September 17, 2020, PRIM&R hosted a webinar, IACUC Operations: Pandemic & Beyond. During this webinar, Dr. Stacy Pritt and Kathryn Cavanaugh, CPIA, shared various methods for conducting IACUC business electronically and virtually and explored employee engagement strategies for keeping IACUC staff connected during a remote work setting. Following the webinar, Stacy and Kathryn reflected on the session and attendee feedback; we're pleased to share their response with the readers of Ampersand. Read more

19
Oct2020

The COVID-19 pandemic has brought many issues to the public’s attention that used to be of interest only to clinical research and drug development communities: clinical trial design, efficiency and timelines of clinical research studies, drugs’ approval process, and pre-approval access to investigational therapies are just a few. Read more

13
Oct2020

On June 18, 2020, PRIM&R hosted a webinar, Complexity in Clinical Trial Design: A Primer on Adaptive and Platform Trials. During this webinar, Luke Gelinas and Marianne Kearney Chase defined key terms, explored ethical and regulatory challenges, and provided strategies and examples to bridge the gap between IRBs and researchers in understanding adaptive trial designs. Following the webinar, Luke and Marianne reflected on the session and attendee feedback; we're pleased to share their response with the readers of Ampersand. Read more